Skip to main content
. 2020 Jun 23;5(26):15805–15811. doi: 10.1021/acsomega.0c00468

Figure 1.

Figure 1

s-Triazine hydrazone derivatives as dual-effective inhibitors against both wild-type (WT) and mutant EGFR TKIs.